(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community' - 2The most effective method to Distinguish the Best Material Organization in Your Space
- 3CPA Canada appoints eight directors as new governance model takes effect
- 4JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
- 5Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield
- Astonishing Deserts All over The Planet You Really want To Visit
- Chevron Says Damage at Wheatstone LNG Will Hamper Restart
- Figure out How to Take part in Open Conversations Around 5G Pinnacles
- Vote in favor of your Number one Sort of Cap
- Want to read more in 2026? Here's how to revive your love of books
- Carina Nebula shines with white-blue stars | Space photo of the day for Jan. 5, 2026
- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- Australians told to continue Easter travel plans despite fuel shortages
- Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
